EFFICACY AND SAFETY OF A NEW VEDOLIZUMAB SUBCUTANEOUS FORMULATION FOR ULCERATIVE COLITIS: RESULTS OF THE VISIBLE 1 PHASE 3 TRIAL

William Sandborn  1     Filip Baert  2     Silvio Danese  3     Ċ½eljko Krznari&#263  4     ;Geert R. D'Haens  5     Taku Kobayashi  6     Xiaopan Yao  7     Jingjing Chen     Krisztina Kisfalvi     Severine Vermeire    
1 University of California San Diego,La Jolla,United States
2 University Hospitals Leuven,Leuven,Belgium
3 Humanitas University,Milan,Italy
4 Clinical Hospital Centre Zagreb,Zagreb,Croatia
5 Academic Medical Centre,Amsterdam,Netherlands
6 Kitasato University Kitasato Institute Hospital,Tokyo,Japan
7 Takeda Development Center Americas Inc.,Ca

Conference
UEG Week 2018

Citation
United European Gastroenterology Journal 2018; 6 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing